Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Use of marijuana and alcohol simultaneously is associated with worse outcomes.

2.

Measurable Residual Disease Predicts Real-World AML Relapse

3.

Alone for 500 Days, but Never Lonely: The Introvert's Dream.

4.

Combination treatment may help cut lifelong ibrutinib for chronic lymphocytic leukemia patients

5.

For treatment, the majority of cancer patients choose complementary therapies.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot